Shareholder Information

Shares can be purchased through a stockbroker of your choice.

The Company shares are listed on The Nasdaq Global Market in the form of American Depository Shares (ADSs). The transfer agent for ADSs is Citigroup. You can contact them as follows:

Citigroup
Depositary Services
388 Greenwich Street
New York
NY 10013
Email: citiadr@citi.com

Please contact our transfer agent, the details of which are provided above. There is a fee for replacing lost certificates.

You must send both your old and new addresses to our transfer agent, the details of which are provided above. Each stockholder in question must sign the request for an address change.

Verona Pharma plc is registered in England and Wales under company number is 5375156 and its registered office is at One Central Square, Cardiff CF10 1FS, Wales, United Kingdom. Our VAT number is 919163219. The Company’s principal office is in central London. The Company’s US office is in North Carolina.

You can view information on our platform and programs by visiting the Pipeline section of our website.

You should contact your physician to discuss if you are eligible to join.

You can view our recent press releases by visiting the News section of our website.

More information can be found on the Verona Pharma website and the SEC website.

All Company updates disclosed to the market can be found here [Links to Investor homepage] Alternatively, you can register to receive updates announced by the Company by subscribing to our Email Alerts here. For specific Investor Relations or Media enquiries, please contact IR@veronapharma.com, our Investor Relations Advisers, Argot Partners (US enquiries).

Argot Partners
767 Third Avenue
34th Floor
New York
NY10017
verona@argotpartners.com
+1-212-600-1902
www.argotpartners.com